118 Participants Needed

Cognitive Empathy Training for Dementia Caregivers

Recruiting at 2 trial locations
KH
JR
Overseen ByJames Rilling, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Emory University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Cognitive Empathy Training for dementia caregivers?

Research shows that training programs focused on empathy can improve caregivers' ability to understand and communicate with people with dementia, leading to better care and improved well-being for both caregivers and patients.12345

Is Cognitive Empathy Training safe for humans?

The research on empathy training, including methods like augmented reality and virtual simulation, suggests these programs are generally safe for caregivers and healthcare providers. They focus on improving empathy and communication skills without reported safety concerns.12467

How is Cognitive Empathy Training different from other treatments for dementia caregivers?

Cognitive Empathy Training is unique because it focuses on enhancing caregivers' ability to understand and share the feelings of people with dementia, which can reduce caregiving anger and improve communication. Unlike other treatments, it may use virtual reality to simulate the dementia experience, helping caregivers develop empathy in a more immersive and impactful way.13458

What is the purpose of this trial?

The goal of this project is to investigate the effect of cognitive empathy training on mental health, inflammation, and immune function in caregivers of people living with dementia (PLWD), and to examine the underlying psychological and neurobiological mechanisms.The primary aim is to establish the effectiveness of cognitive empathy training in improving caregiver mental health and immune function, and in decreasing caregiver inflammationThe secondary aim is to investigate the psychological and neurobiological mechanism by which cognitive empathy training improves caregiver well-being

Research Team

JR

James Rilling, PhD

Principal Investigator

Emory College of Arts & Sciences

KH

Kenneth Hepburn, PhD

Principal Investigator

Emory School of Nursing

Eligibility Criteria

This trial is for caregivers of individuals with dementia, including Alzheimer's Disease. Participants should be in good general health and willing to undergo empathy training as well as pre and post intervention assessments like blood spot collection and MRI sessions.

Inclusion Criteria

Caregivers must be able to read and write English
Care recipient not in hospice
Caregivers must live with their care recipient
See 3 more

Exclusion Criteria

Subjects with a history of seizures or other neurological disorders, alcoholism, or any other substance abuse
Subjects with a history of head trauma based on Survey
Subjects with MRI contra-indications
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Empathy Training

Participants receive cognitive empathy training through a photo captioning intervention

6 months
Assessments at baseline, 10-day, and 6-month

Crossover

Participants crossover to the control condition or initiate the intervention

6 months
Assessments at 6-month and 10-day post-crossover

Follow-up

Participants are monitored for safety and effectiveness after the intervention

6 months
Assessment at 12-month completion

Treatment Details

Interventions

  • Cognitive Empathy Training
Trial Overview The study tests if cognitive empathy training can improve mental health, reduce inflammation, and boost immune function in dementia caregivers. It includes a control group for comparison and uses blood tests and MRIs to measure changes before and after the training.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Group 2: Control ConditionExperimental Treatment3 Interventions
During the first phase of the study, participants in Group 2 are controls. At the 6-month time point, participants in Group 2 will crossover and initiate the intervention. Assessments will be collected at baseline, 10-day (immediate post-training), 6-month (crossover), 6-month and 10-day (immediate post-crossover), and 12-month (completion)
Group II: Group 1: Empathy TrainingExperimental Treatment3 Interventions
Participants will be randomly assigned to the empathy training or control condition for 6 months. During the first phase of the study, participants in Group 1 will receive the photo captioning intervention. At the 6-month time point, participants in Group 1 will crossover to control. Assessments will be collected at baseline, 10-day (immediate post-training), 6-month (crossover), 6-month and 10-day (immediate post-crossover) and 12-month (completion)

Find a Clinic Near You

Who Is Running the Clinical Trial?

Emory University

Lead Sponsor

Trials
1,735
Recruited
2,605,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Findings from Research

The AREduX program uses augmented reality to simulate the physical and cognitive challenges faced by people living with dementia, aiming to enhance empathy among healthcare providers and caregivers.
This innovative training approach is designed to improve patient care and satisfaction by fostering empathetic responses, addressing a significant gap in existing empathy training programs for healthcare professionals.
Augmented Reality Education Experience (AREduX): An Augmented Reality Experience and Experiential Education Medium to Teach Empathy to Healthcare Providers and Caregivers of Persons Living With Dementia.Hollaender, G., Peisachovich, E., Kapralos, B., et al.[2023]

References

Interventions to Enhance Empathy and Person-Centered Care for Individuals With Dementia: A Systematic Review. [2021]
Empathy Training for Caregivers of Older People: A Systematic Review. [2022]
Use and impact of virtual reality simulation in dementia care education: A scoping review. [2020]
Virtual simulation training: Imaged experience of dementia. [2020]
The effect of multimodal comprehensive care methodology training on oral health care professionals' empathy for patients with dementia. [2021]
Augmented Reality Education Experience (AREduX): An Augmented Reality Experience and Experiential Education Medium to Teach Empathy to Healthcare Providers and Caregivers of Persons Living With Dementia. [2023]
A factorial randomized controlled trial to examine separate and combined effects of a simulation-based empathy enhancement program and a lecture-based education program on family caregivers of people with dementia. [2021]
What You Believe Can Affect How You Feel: Anger Among Caregivers of Elderly People With Dementia. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity